Stock MGTA MAGENTA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

News Magenta Therapeutics

Equities

MGTA

US55910K1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
21.32 USD -8.97% Intraday chart for Magenta Therapeutics -8.65% +90.47%
2023 Magenta Therapeutics, Inc.(NasdaqCM:MGTA) dropped from NASDAQ Composite Index CI
2023 Dianthus Therapeutics, Inc. completed the acquisition of Magenta Therapeutics, Inc. from a group of shareholders in a reverse merger transaction. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Adrenoleukodystrophy Clinical Trials, and Key Companies|Companies - Bluebird Bio, Minoryx Therapeutics, MedDay Pharmaceuticals, Magenta Therapeutics, Orpheris Inc, SOM Biotech, and many others
AQ
Magenta Therapeutics, Inc.(NasdaqCM:MGTA) dropped from NASDAQ Composite Index
CI
Dianthus Therapeutics, Inc. completed the acquisition of Magenta Therapeutics, Inc. from a group of shareholders in a reverse merger transaction.
CI
North American Morning Briefing : PCE Inflation -2-
DJ
North American Morning Briefing : Nasdaq Futures -2-
DJ
North American Morning Briefing : Treasury Yields Keep Pushing Higher
DJ
North American Morning Briefing : Attention Turns -2-
DJ
MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA
BU
Magenta Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Magenta Therapeutics, Inc.(NasdaqGM:MGTA) dropped from Russell Microcap Index
CI
Magenta Therapeutics, Inc.(NasdaqGM:MGTA) dropped from Russell Microcap Value Index
CI
Magenta Therapeutics, Inc.(NasdaqGM:MGTA) dropped from Russell 3000E Value Index
CI
Magenta Therapeutics, Inc.(NasdaqGM:MGTA) dropped from Russell 3000E Index
CI
Magenta Therapeutics, Inc. Announces Resignation of Lisa Olson as Head of Research and Chief Scientific Officer
CI
Magenta Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
North American Morning Briefing : Hopes Build for -3-
DJ
MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA
BU
Transcript : Dianthus Therapeutics, Inc., Magenta Therapeutics, Inc. - M&A Call
MAGENTA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MGTA Stock
  4. News Magenta Therapeutics